Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

BILCARE 2022-23 Annual Report Analysis
Wed, 25 Oct

BILCARE has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

BILCARE Income Statement Analysis

  • Operating income during the year rose 16.2% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 217.3% YoY during the fiscal. Operating profit margins witnessed a fall and down at 28.9% in FY23 as against 10.6% in FY22.
  • Depreciation charges decreased by 3.7% and finance costs decreased by 13.0% YoY, respectively.
  • Other income declined by 29.2% YoY.
  • Net profit for the year declined by NA YoY.
  • Net profit margins during the year grew from 0.5% in FY22 to 5.1% in FY23.

BILCARE Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 8,447 9,815 16.2%
Other income Rs m 146 103 -29.2%
Total Revenues Rs m 8,593 9,918 15.4%
Gross profit Rs m 894 2,836 217.3%
Depreciation Rs m 393 378 -3.7%
Interest Rs m 689 600 -13.0%
Profit before tax Rs m -42 1,961 NA
Tax Rs m 1 1,459 108,759.0%
Profit after tax Rs m -44 502 NA
Gross profit margin % 10.6 28.9
Effective tax rate % -3.2 74.4
Net profit margin % -0.5 5.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

BILCARE Balance Sheet Analysis

  • The company's current liabilities during FY23 down at Rs 3 billion as compared to Rs 4 billion in FY22, thereby witnessing an decrease of -17.3%.
  • Long-term debt down at Rs 5 billion as compared to Rs 5 billion during FY22, a fall of 4.2%.
  • Current assets fell 20% and stood at Rs 3 billion, while fixed assets rose 111% and stood at Rs 13 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 16 billion as against Rs 10 billion during FY22, thereby witnessing a growth of 57%.

BILCARE Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 751 5,306 606.2
 
Current Liabilities Rs m 4,026 3,331 -17.3
Long-term Debt Rs m 5,369 5,145 -4.2
Total Liabilities Rs m 10,129 15,877 56.8
 
Current assets Rs m 4,206 3,377 -19.7
Fixed Assets Rs m 5,923 12,500 111.0
Total Assets Rs m 10,129 15,877 56.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



BILCARE Cash Flow Statement Analysis

  • BILCARE's cash flow from operating activities (CFO) during FY23 stood at Rs -70 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs 362 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs -189 million, an improvement of 66% on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs 103 million from the Rs -179 million net cash flows seen during FY22.

BILCARE Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m 413 -70 -
Cash Flow from Investing Activities Rs m -43 362 -
Cash Flow from Financing Activities Rs m -549 -189 -
Net Cash Flow Rs m -179 103 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for BILCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 21.3, an improvement from the EPS of Rs -1.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 73.6, stands at 4.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 0.3 times, while the price to sales ratio stands at 0.2 times.
  • The company's price to cash flow (P/CF) ratio stood at 1.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 358.7 416.8
TTM Earnings per share Rs -1.9 21.3
Diluted earnings per share Rs -1.9 21.3
Price to Cash Flow x 4.7 1.5
TTM P/E ratio x -37.5 4.0
Price / Book Value ratio x 2.6 0.3
Market Cap Rs m 1,987 1,362
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for BILCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.0x during FY23, from 1.0x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 4.3x during FY23, from 0.9x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 9.5% during FY23, from -5.8% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 24.5% during FY23, from 10.6% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 6.9% during FY23, from 6.4% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 1.0 1.0
Debtors’ Days Days 951 699
Interest coverage x 0.9 4.3
Debt to equity ratio x 7.1 1.0
Return on assets % 6.4 6.9
Return on equity % -5.8 9.5
Return on capital employed % 10.6 24.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how BILCARE has performed over the last 5 years, please visit here.

BILCARE Share Price Performance

Over the last one year, BILCARE share price has moved up from Rs 54.0 to Rs 73.6, registering a gain of Rs 19.7 or around 36.4%.

Overall, the S&P BSE SENSEX is up 8.2% over the year.

(To know more, check out historical annual results for BILCARE and quarterly results for BILCARE)

Annual Report FAQs

What is the current share price of BILCARE?

BILCARE currently trades at Rs 55.2 per share. You can check out the latest share price performance of BILCARE here...

What was the revenue of BILCARE in FY23? How does it compare to earlier years?

The revenues of BILCARE stood at Rs 9,918 m in FY23, which was up 15.4% compared to Rs 8,593 m reported in FY22.

BILCARE's revenue has fallen from Rs 30,573 m in FY19 to Rs 9,918 m in FY23.

Over the past 5 years, the revenue of BILCARE has grown at a CAGR of -24.5%.

What was the net profit of BILCARE in FY23? How does it compare to earlier years?

The net profit of BILCARE stood at Rs 502 m in FY23, which was NA compared to Rs -44 m reported in FY22.

This compares to a net loss of Rs -112 m in FY21 and a net loss of Rs -990 m in FY20.

Over the past 5 years, BILCARE net profit has grown at a CAGR of NaN%.

What does the cash flow statement of BILCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of BILCARE reveals:

  • Cash flow from operations decreased in FY23 and stood at Rs -70 m as compared to Rs 413 m in FY22.
  • Cash flow from investments increased in FY23 and stood at Rs 362 m as compared to Rs -43 m in FY22.
  • Cash flow from financial activity increased in FY23 and stood at Rs -189 m as compared to Rs -549 m in FY22.

Here's the cash flow statement of BILCARE for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations2,0562,562718413-70
From Investments-1,03813,09417-43362
From Financial Activity-1,026-16,001-827-549-189
Net Cashflow-9-346-92-179103

What does the Key Ratio analysis of BILCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of BILCARE reveals:

  • Operating profit margins witnessed a fall and down at 28.9% in FY23 as against 10.6% in FY22.
  • Net profit margins grew from 0.5% in FY22 to 5.1% in FY23.
  • Debt to Equity ratio for FY23 stood at 1.0 as compared to 7.1 in FY22.

Here's the ratio/financial analysis of BILCARE for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)5.611.112.510.628.9
Net Profit Margin (%)-15.1-5.4-1.8-0.55.1
Debt to Equity Ratio (x)-10.75.26.17.11.0

Equitymaster requests your view! Post a comment on "BILCARE 2022-23 Annual Report Analysis". Click here!